THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 16 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 17,000,000 | $19,327,000 | 6.15% |
| LINDEN ADVISORS LP | 42,667,000 | $48,959,000 | 1.91% |
| Context Capital Management, LLC | 1,500,000 | $1,730,000 | 1.90% |
| Mohican Financial Management, LLC | 1,000,000 | $1,137,000 | 1.42% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 9,000,000 | $10,407,000 | 0.99% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,500,000 | $36,304,000 | 0.65% |
| Verition Fund Management LLC | 6,000,000 | $6,851,000 | 0.59% |
| BlueCrest Capital Management Ltd | 9,167,000 | $10,570,000 | 0.58% |
| TFG Asset Management GP Ltd | 2,500,000 | $2,885,000 | 0.57% |
| Weiss Asset Management LP | 3,000,000 | $3,446,000 | 0.52% |